Compare
NAVs as of 20 Aug 2026
Add a second fund to compare. Until then every figure below is shown against the Index Funds median (366 funds), which is the only comparison one fund can support.
Growth of ₹100 (rebased over the selected window)
Common period 22 Feb 2019 – 20 Aug 2026, limited by DSP Nifty 50 Index Fund. Every series is rebased to ₹100 at the start of this window. Benchmark lines are the category index WealthTicker measures against, which is not always the benchmark the scheme itself declares — the fund page’s Scheme Info names that one.
View as table
| Date | DSP Nifty 50 Index Fund | Nifty 50 |
|---|---|---|
| 22 Feb 2019 | ₹100.00 | ₹100.00 |
| 08 Oct 2019 | ₹103.63 | ₹103.10 |
| 23 May 2020 | ₹84.07 | ₹83.76 |
| 06 Jan 2021 | ₹131.91 | ₹131.09 |
| 22 Aug 2021 | ₹154.23 | ₹152.44 |
| 07 Apr 2022 | ₹165.65 | ₹163.46 |
| 21 Nov 2022 | ₹171.94 | ₹168.28 |
| 07 Jul 2023 | ₹183.51 | ₹179.14 |
| 20 Feb 2024 | ₹211.63 | ₹205.69 |
| 05 Oct 2024 | ₹239.62 | ₹231.80 |
| 21 May 2025 | ₹238.31 | ₹229.93 |
| 04 Jan 2026 | ₹254.63 | ₹243.97 |
| 20 Aug 2026 | ₹235.96 | ₹224.54 |
| Metric | DSP · Regular NAV ₹23.59 Very High risk ★★★★☆ | Category median Index Funds · 366 funds |
|---|---|---|
| -2.55% | +5.43% | |
| +8.67% | +8.41% | |
| +8.88% | +8.95% | |
| — | +11.28% | |
| +12.14% | +7.40% | |
| +7.25% | — | |
| +15.02% | +11.37% | |
| +15.45% | +13.00% | |
| — | +11.07% | |
| Risk | ||
| 13.19% | 13.88% | |
| 0.16 | 0.25 | |
| 0.23 | 0.35 | |
| -37.80% | -16.66% | |
| Nifty 50 | — | |
| +0.76% | +0.30% | |
| 1.00 | 1.00 | |
| 101.7% | 101.3% | |
| 97.2% | 98.8% | |
| 0.44% | 0.96% | |
| ₹1,074Cr | ₹182.17Cr | |
| None | — | |
| None | — | |
| ₹100 | — | |
| ₹100 | — | |
| 58% | 35% | |
| Anil Ghelani | — | |
| 22 Feb 2019 | — | |
| 50 | — | |
| 53.3% | — | |
| 0.5% | — | |
Best marks the strongest value in a row, and only where the gap is bigger than noise — a near-tie is left unmarked rather than dressed up as a result. SIP XIRR is a ₹10,000/month instalment over 5 years of real NAV history. Nothing here is supplied by a fund house. For research only — not investment advice.